trending Market Intelligence /marketintelligence/en/news-insights/trending/9WCD1Hd6bvcjy4OMKtOfRg2 content esgSubNav
In This List

Argos Therapeutics expands board

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Argos Therapeutics expands board

Argos Therapeutics Inc. added Ralph Snyderman and Irackly Mtibelishvily to its board.

Snyderman is the director of the Duke Center for Research on Personalized Health Care while Mtibelishvily is Citigroup's managing director and chairman of corporate and investment banking in central and eastern Europe, the Middle East and Africa.